Effects of non-invasive vagus nerve stimulation on clinical symptoms and molecular biomarkers in Parkinson’s disease
Non-invasive vagus nerve stimulation (nVNS) is an established neurostimulation therapy used in the treatment of epilepsy, migraine and cluster headache. In this randomized, double-blind, sham-controlled trial we explored the role of nVNS in the treatment of gait and other motor symptoms in Parkinson...
Main Authors: | Banashree Mondal, Supriyo Choudhury, Rebecca Banerjee, Akash Roy, Koustav Chatterjee, Purba Basu, Ravi Singh, Saptak Halder, Shantanu Shubham, Stuart N. Baker, Mark R. Baker, Hrishikesh Kumar |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-02-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnagi.2023.1331575/full |
Similar Items
-
Non-invasive vagus nerve stimulation improves clinical and molecular biomarkers of Parkinson’s disease in patients with freezing of gait
by: Banashree Mondal, et al.
Published: (2021-05-01) -
Retraction Note: Non-invasive vagus nerve stimulation improves clinical and molecular biomarkers of Parkinson’s disease in patients with freezing of gait
by: Banashree Mondal, et al.
Published: (2022-11-01) -
Safety and tolerability of adjunct non-invasive vagus nerve stimulation in people with parkinson’s: a study protocol
by: Hilmar P. Sigurdsson, et al.
Published: (2023-02-01) -
Low-dose clozapine-induced agranulocytosis in patients with movement disorders—Retrospective study from India
by: Supriyo Choudhury, et al.
Published: (2021-01-01) -
Analysis of gait in Parkinson’s disease reflecting the effect of l-DOPA
by: Banashree Mondal, et al.
Published: (2019-01-01)